Infectious disease specialists at Rush diagnosis and treat people with all types of infectious diseases. This includes a wide range of diseases caused by germs such as bacteria, viruses, fungi and parasites. The section has several areas of special expertise, including the following:
HIV infection and AIDS
Infections in organ transplant patients
To combat normal host rejection mechanisms, patients who receive organ transplants must take medications that suppress their immune systems. These medications increase susceptibility to infections. The section provides consultations and direct patient care to organ transplant patients who develop infections. For more information, contact Carlos Santos, MD.
The section offers care for patients who develop orthopedic infections. Treatment is available for patients with infections of both bone and prosthetic devices. Patients may receive care both before and after surgery. In many of these patients, the section supervises long-term antibiotic therapy. For more information, contact John Segreti, MD.
The section offers evaluation and treatment for patients with tropical infections contracted while abroad. While most tropical infections do not pose a health threat to people in the U.S., some can be easily contracted while Americans visit other parts of the world. These infections are often difficult to recognize and treat, and may require special expertise. For more information, contact Gordon Trenholme, MD.
Invasive fungal infections
Physicians in the section diagnose and treat invasive fungal infections. The section has special expertise in managing these infections in people with weakened immune systems. Patients have access to standard treatment, as well as the latest therapies being studied in clinical trials. For more information, contact Laurie Proia, MD.
Hospital-acquired infections are difficult to treatment, because many of the bacteria that cause them are resistant to commonly used antibiotics. Treating antibiotic-resistant infections requires special expertise. The section conducts clinical trials of new medications designed to combat difficult-to-treat microorganisms. For more information, contact John Segreti, MD or Mary Hayden, MD.